脑血管支架市场规模、份额和成长分析（按材料、最终用户和地区）- 产业预测 2025-2032

2023年全球脑血管支架市场规模价值4亿美元，预计将从2024年的4.3亿美元成长到2032年的8.2亿美元，预计在预测期内（2025-2032年）的复合年增长率为8.3%。

由于脑部疾病发生率不断上升和人口老化，预计脑血管支架市场将显着增长。这些微小的网状管对于治疗脑动脉瘤和确保狭窄动脉的正常血流至关重要，随着微创手术技术越来越普及，它们的应用也越来越广泛。医疗技术的创新以及可生物吸收支架的采用预计将为市场参与者提供充足的机会。然而，某些支架高成本和潜在的手术併发症等挑战可能会抑制市场扩张。此外，越来越多的监管机构核准新疗法，可能会刺激对脑血管支架的需求，从而在未来创造一个充满希望的市场。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析

脑血管支架市场规模（按材料和复合年增长率） (2025-2032)

• 市场概况
• 钽
• 不銹钢
• 镍钛合金

脑血管支架市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 门诊手术中心
• 医疗中心
• 其他的

脑血管支架市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Medtronic plc（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Stryker Corporation（USA）
• Johnson & Johnson（USA）
• MicroPort Scientific Corporation（China）
• Penumbra, Inc.（USA）
• Asahi Intecc Co., Ltd.（Japan）
• Integer Holdings Corporation（USA）
• B. Braun Melsungen AG（Germany）
• Biotronik SE & Co. KG（Germany）
• Merit Medical Systems, Inc.（USA）
• Kaneka Medix Corp.（Japan）
• Acandis GmbH（Germany）
• Balt（Switzerland）
• Rapid Medical（Israel）
• Medinol Ltd.（Israel）

结论和建议

Global Cerebral Vascular Stent Market size was valued at USD 0.4 billion in 2023 and is poised to grow from USD 0.43 billion in 2024 to USD 0.82 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The cerebral vascular stent market is poised for significant growth, driven by the rising prevalence of cerebral disorders and an aging population. These small mesh tubes, crucial for treating brain aneurysms and ensuring proper blood flow in constricted arteries, are increasingly utilized as minimally invasive surgical techniques gain traction. Innovations in healthcare technology, along with the adoption of bioabsorbable stents, are expected to present ample opportunities for market players. However, challenges such as the high costs of certain stents and potential procedural complications may restrain market expansion. Moreover, increased regulatory approvals for novel treatments will likely enhance the demand for cerebral vascular stents, positioning the market for a promising future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cerebral Vascular Stent market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cerebral Vascular Stent Market Segmental Analysis

Global Cerebral Vascular Stent Market is segmented by Material, End User and region. Based on Material, the market is segmented into Tantalum, Stainless Steel and Nitinol. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Medical Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cerebral Vascular Stent Market

The rising global geriatric population is a significant driving force behind the expansion of the cerebral vascular stent market. As the number of elderly individuals continues to grow, so does their susceptibility to various cerebral and vascular conditions that necessitate medical interventions. This increasing demographic trend implies a higher demand for cerebral vascular stents to address the health needs of older patients. Consequently, healthcare providers and manufacturers are likely to focus on developing and delivering innovative stenting solutions to cater to the unique requirements of this aging population, ultimately contributing to market growth in the sector.

Restraints in the Global Cerebral Vascular Stent Market

Restraints on the global cerebral vascular stent market include the significant costs associated with cerebral procedures. Surgical interventions involving the brain can be prohibitively expensive due to the requirement for advanced medical technology and the expertise of highly trained healthcare professionals. As a result, these elevated costs are anticipated to hinder the sales growth of cerebral vascular stents in the coming years. Patients may be deterred from undergoing necessary procedures due to financial constraints, ultimately impacting the overall market dynamics and limiting accessibility to crucial treatments for cerebral vascular conditions.

Market Trends of the Global Cerebral Vascular Stent Market

The Global Cerebral Vascular Stent market is experiencing a significant shift towards innovative materials, particularly bioabsorbable stents, which offer the dual benefits of effective vascular support and post-treatment absorption, thereby minimizing the risk of long-term complications. This trend is complemented by the increasing demand for drug-eluting stents that release therapeutic agents, further enhancing treatment outcomes. Together, these developments are fostering a wave of advanced solutions aimed at improving patient safety and recovery. As manufacturers invest in research and development to integrate bioabsorbable materials with drug-eluting technology, the market is poised for substantial growth, driven by enhanced patient-centric solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cerebral Vascular Stent Market Size by Material & CAGR (2025-2032)

• Market Overview
• Tantalum
• Stainless Steel
• Nitinol

Global Cerebral Vascular Stent Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Medical Centres
• Others

Global Cerebral Vascular Stent Market Size & CAGR (2025-2032)

• North America (Material, End User)
  • US
  • Canada
• Europe (Material, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Medix Corp. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medinol Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations